Syngene, the CRO arm of Indian biotech giant Biocon, is poised to swell about 20% a year, Managing Director Kiran Mazumdar-Shaw said, making it the continent's fastest-growing service provider. Last year, Syngene grew about 36% to $102.7 million in revenue. Article